OrbiMed Capital GP IX LLC (CIK 1920574) reported 5 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-08-11). Recent activity: Buy BRVE (9.1M shares), Buy BRVE (1.7M shares), Buy BRVE (273,333 shares), Buy STTK (5.3M shares), Buy STTK (1.1M shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-11 | Braveheart Bio, Inc. (BRVE) | Director | Buy | 9.1M | $0 |
| 2026-08-11 | Braveheart Bio, Inc. (BRVE) | Director | Buy | 1.7M | $30.0M |
| 2026-08-11 | Braveheart Bio, Inc. (BRVE) | Director | Buy | 273,333 | $4.9M |
| 2025-09-02 | Shattuck Labs, Inc. (STTK) | Director | Buy | 5.3M | $4.6M |
| 2025-09-02 | Shattuck Labs, Inc. (STTK) | Director | Buy | 1.1M | $914,388 |
Source: SEC Form 4 filings · as of 2026-08-11